[(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate

C34H50O11 — CID 86573193

IUPAC[(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate
SMILESCOCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@]3(O)C2C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]2(C)[C@]3(O)CC[C@@]2(OC(=O)COC)C(C)=O)C1
InChIInChI=1S/C34H50O11/c1-20(2)21(3)15-27(36)44-26-17-25-30(5)11-10-24(43-28(37)18-41-7)16-23(30)9-12-32(25,39)34(40)14-13-33(22(4)35,31(26,34)6)45-29(38)19-42-8/h9,15,20,24-26,39-40H,10-14,16-19H2,1-8H3/b21-15+/t24-,25?,26+,30-,31+,32-,33+,34+/m0/s1
InChIKeyMEFWKOYYEJJFCG-NEFLOXCESA-N
MW634.76 g/mol
LogP3.38
Rot. Bonds10

About [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate

[(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate (PubChem CID 86573193) has the molecular formula C34H50O11 and a molecular weight of 634.76 g/mol. Its IUPAC name is [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate.

Molecular Properties

Compound Name[(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate
PubChem CID86573193
Molecular FormulaC34H50O11
Molecular Weight634.76 g/mol
Exact Mass634.34
IUPAC Name[(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate
SMILESCOCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@]3(O)C2C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]2(C)[C@]3(O)CC[C@@]2(OC(=O)COC)C(C)=O)C1
InChIInChI=1S/C34H50O11/c1-20(2)21(3)15-27(36)44-26-17-25-30(5)11-10-24(43-28(37)18-41-7)16-23(30)9-12-32(25,39)34(40)14-13-33(22(4)35,31(26,34)6)45-29(38)19-42-8/h9,15,20,24-26,39-40H,10-14,16-19H2,1-8H3/b21-15+/t24-,25?,26+,30-,31+,32-,33+,34+/m0/s1
InChIKeyMEFWKOYYEJJFCG-NEFLOXCESA-N
XLogP3.38
TPSA154.89 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds10
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500634.76
LogP ≤ 53.38
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate?
The IUPAC name of [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate (CID 86573193) is [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate.
What is the SMILES notation for [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate?
The canonical SMILES for [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate is COCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@]3(O)C2C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]2(C)[C@]3(O)CC[C@@]2(OC(=O)COC)C(C)=O)C1.
What is the InChIKey of [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate?
The InChIKey is MEFWKOYYEJJFCG-NEFLOXCESA-N. The full InChI is InChI=1S/C34H50O11/c1-20(2)21(3)15-27(36)44-26-17-25-30(5)11-10-24(43-28(37)18-41-7)16-23(30)9-12-32(25,39)34(40)14-13-33(22(4)35,31(26,34)6)45-29(38)19-42-8/h9,15,20,24-26,39-40H,10-14,16-19H2,1-8H3/b21-15+/t24-,25?,26+,30-,31+,32-,33+,34+/m0/s1.
What are the key properties of [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate?
[(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate has a molecular weight of 634.76 g/mol, XLogP of 3.38, 10 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-8,14-dihydroxy-3,17-bis[(2-methoxyacetyl)oxy]-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl] (E)-3,4-dimethylpent-2-enoate is sourced from PubChem (CID 86573193), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).